Prevalence of peripheral neuropathy among patients with diabetes mellitus at King Hussein hospital, Amman, Jordan

To determine the prevalence of prevalence peripheral neuropathy [PN] among patients with Diabetes Mellitus [DM] at King Hussein hospital. This descriptive study was done at King Hussein Hospital, Amman, Jordan and included 202 patients od DM using convenience sampling technique. Data were collected through face-to-face interview. Data collection instrument is composed of two parts; the first part assessed the demographic characteristics, while the second part was a translated version of Michigan Neuropathy Screening Instrument [MNSI]. Descriptive and inferential statistics were used for data analysis. Out of 202 patients, 102 were male and 100 female. The age ranged from 16 to 88 years [mean 56.19 +/- 14.31]. The mean duration of diabetes was 10.69 +/- 8.24 years. The overall prevalence of PN was 54.45 +/- 49.92. The prevalence was higher in women than men [55 +/- 50 VS 53.92 +/- 50.09]. There was significantly higher prevalence of PN among patients with non target glycosylated hemoglobin [HbAIc] [p<0.05], age ? 65 years [p<0.05], duration of diabetes ?10 years and body Mass index [BMI] ?25 kg/m2 [p<0.05]. The prevalence of peripheral neuropathy was high. Diabetic patient should be screened for PN continuously using simple instrument such MNSI. The initial measures that may help in prevention of PN were glycemic control and body weight control

Impact of age, gender, diabetes mellitus duration and body mass index on metabolic control of type 2dm among a group of Jordanian patients

To assess the impact of age, gender, duration of diabetes and body mass index confounders on diabetes control among a Jordanian cohort of T2DM at the Endocrine Clinic in King Hussein Medical Center. Patients were selected over 18 months from outpatient clinic at King Hussein Medical Center in Amman-Jordan. Diabetes control assessed by mean of latest 3 HbA1c and fasting blood sugar. Patients were divided in 2 groups according to age [55 years], gender, duration [10 years] and BMI [normal, overweight, and obese according to WHO criteria]. Statistical analysis is performed using SPSS11.5.Good diabetes control is assessed according to American Diabetes Association criteria A total of 405 patients were selected [223 males, 182 females]. 115 patients [28.4%] were having a good control with HbA1c 55 years [n=222] [29%vs.28%; p=0.812]. Females in both age groups were having non statistically significant better control than males. Of those with DM duration 10 years duration [n=163] [P-value=0.001, RR=1.83, OR=2.26]. Females were again having a better diabetic control in both duration groups, p=0.024. There was no statically significant difference in diabetic control in all BMI categories studied. Thirty percent of overweight patients were having good control Vs 10 year. The mean HBA1C of the group aged< 55 years was 8.1 +/- 1.8 Vs 7.9 +/- 1.5 in those >55 years of age. In this Jordanian group with T2DM the diabetic control was modest at 28.4%. Females were having a better diabetic control at all categories. Diabetes duration less 10 years was the only indicator of adequate control of diabetes